Home Formulation Business Markets

Latin America

Marksans aims to penetrate the Latin American market with its high quality products and extensive product portfolio. Strong economic performance in this region is expected to fuel growth in the coming years. In addition, recent regulatory developments will create further market opportunities in the country, particularly for generic producers in both the private and public sectors.

In Ecuador, the pharmaceutical industry is expected to perform well in the coming years, with strong growth in production, sales, exports and employment. Pharmaceutical companies, however, are encouraged to act in smaller Latin American markets to maximize their full regional sales potential.

Generics consumption in Latin America is high. Marksans Pharma is currently operating in Central America, South America & Caribbean Islands with 15 products registered and 70 products are submitted to MOH (Ministry of Health).

  • Cefepime 2g
  • Meropenem 500
  • Imipenem /Cilastatin 500mg
  • Omeprazole 40mg
  • Cefuroxime 250, 500mg
  • Telmisartan
  • Ceftiaxone 1gm
  • Cephalosporins
  • Antibiotics
  • Cardiovascular
  • Injectables
  • Ecuador
  • Jamaica
  • Nicaragua
  • Central America
  • South America
  • Caribbean Islands